1
|
Naessens C, Laloze J, Leobon S, Gauthier T, Lacorre A, Monteil J, Venat L, Deluche E. Physician compliance with multidisciplinary tumor board recommendations for managing gynecological cancers. Future Oncol 2023; 19:897-908. [PMID: 37232140 DOI: 10.2217/fon-2022-1183] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/27/2023] Open
Abstract
Aims: Evaluation of compliance with gynecological multidisciplinary tumor board (MTB) recommendations and its impact. Patients & methods: All patient records discussed in our MTB from 2018 to 2020 were analyzed. Results: We analyzed 437 MTB recommendations concerning 166 patients. Each patient was discussed an average of 2.6 (1.0-4.2) times. Of the 789 decisions, the decision was not followed 102 times (12.9%), corresponding to 85 MTB meetings (19.5%). Of these, 72 recommendations concerned therapeutic changes (70.5%), and 30 concerned non-therapeutic changes (29.5%). Of these 85 MTB decisions, 60 (71%) led to a new MTB submission. Noncompliance with MTB decisions decreased the overall survival (46 vs 138 months; p = 0.003). Conclusion: Improving compliance with MTB decisions is crucial to enhance patient outcomes.
Collapse
Affiliation(s)
- Clara Naessens
- Radiation Therapy Department, Limoges University Hospital, Limoges, 87000, France
| | - Jerome Laloze
- Reconstructive Surgery Department, Limoges University Hospital, Limoges, 87000, France
| | - Sophie Leobon
- Medical Oncology Department, Limoges University Hospital, Limoges, 87000, France
| | - Tristan Gauthier
- Gynecological Department, Limoges University Hospital, Limoges, 87000, France
| | - Aymeline Lacorre
- Gynecological Department, Limoges University Hospital, Limoges, 87000, France
| | - Jacques Monteil
- Nuclear Medicine Department, Limoges University Hospital, Limoges, 87000, France
| | - Laurence Venat
- Medical Oncology Department, Limoges University Hospital, Limoges, 87000, France
| | - Elise Deluche
- Medical Oncology Department, Limoges University Hospital, Limoges, 87000, France
| |
Collapse
|
2
|
Elmore SNC, Mushonga M, Iyer HS, Kanda C, Chibonda S, Chipidza F, Makunike Mutasa R, Muchuweti D, Muguti EG, Maunganidze A, Ndlovu N, Bellon JR, Nyakabau AM. Breast cancer in Zimbabwe: patterns of care and correlates of adherence in a national referral hospital radiotherapy center cohort from 2014 to 2018. Cancer Med 2021; 10:3489-3498. [PMID: 33973399 PMCID: PMC8178482 DOI: 10.1002/cam4.3764] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2020] [Revised: 12/24/2020] [Accepted: 12/26/2020] [Indexed: 12/24/2022] Open
Abstract
Background Breast cancer is the second most common cancer among women in Zimbabwe. Patients face socioeconomic barriers to accessing oncology care, including radiotherapy. We sought to understand patterns of care and adherence for women with breast cancer in sub‐Saharan Africa (SSA) with radiotherapy access. Methods A retrospective cohort was created for women with breast cancer evaluated at the Parirenyatwa Hospital Radiotherapy and Oncology Center (RTC) from 2014 to 2018. Clinical data were collected to define patterns of care. Non‐adherence was modeled as a binary outcome with different criteria for patients with localized versus metastatic disease. Results In total, 351 women presented with breast cancer with median age 51 at diagnosis (IQR: 43–61). Receptor status was missing for 71% (248). 199 (57%) had non‐metastatic disease, and 152 (43%) had metastases. Of women with localized disease, 34% received post‐mastectomy radiation. Of women with metastatic disease, 9.7% received radiotherapy. Metastatic disease and missing HIV status were associated with increased odds of study‐defined non‐adherence (aOR: 1.85, 95% CI: 1.05, 3.28; aOR: 2.13, 95% CI: 1.11, 4.05), while availability of ER/PR status was associated with lower odds of non‐adherence (aOR: 0.18, 95% CI: 0.09, 0.36). Conclusions Radiotherapy is likely underutilized for women with breast cancer, even in a setting with public sector availability. Exploring patient‐level factors that influence adherence to care may provide clinicians with better tools to support adherence and improve survival. Greater investment is needed in multidisciplinary, multimodality care for breast cancer in SSA.
Collapse
Affiliation(s)
- Shekinah Nefreteri Cluff Elmore
- Harvard Radiation Oncology Program, Boston, USA.,Harvard Medical School, Boston, USA.,Department of Radiation Oncology, University of North Carolina, Chapel Hill, USA
| | - Melinda Mushonga
- Parirenyatwa Hospital Radiotherapy and Oncology Center, Harare, Zimbabwe
| | | | - Caroline Kanda
- Parirenyatwa Hospital Radiotherapy and Oncology Center, Harare, Zimbabwe
| | - Shirley Chibonda
- Parirenyatwa Hospital Radiotherapy and Oncology Center, Harare, Zimbabwe
| | - Fallon Chipidza
- Harvard Radiation Oncology Program, Boston, USA.,Harvard Medical School, Boston, USA.,Department of Radiation Oncology, Dana-Faber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts, USA
| | - Rudo Makunike Mutasa
- Department of Pathology, University of Zimbabwe, College of Health Sciences, Harare, Zimbabwe
| | - David Muchuweti
- Department of Surgery, University of Zimbabwe, College of Health Sciences, Harare, Zimbabwe
| | - Edwin G Muguti
- Department of Surgery, University of Zimbabwe, College of Health Sciences, Harare, Zimbabwe
| | - Aspect Maunganidze
- Department of Surgery, University of Zimbabwe, College of Health Sciences, Harare, Zimbabwe
| | - Ntokozo Ndlovu
- Parirenyatwa Hospital Radiotherapy and Oncology Center, Harare, Zimbabwe.,Department of Oncology, University of Zimbabwe, College of Health Sciences, Harare, Zimbabwe
| | - Jennifer Ruth Bellon
- Department of Radiation Oncology, Dana-Faber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts, USA
| | - Anna Mary Nyakabau
- Parirenyatwa Hospital Radiotherapy and Oncology Center, Harare, Zimbabwe.,Department of Pathology, University of Zimbabwe, College of Health Sciences, Harare, Zimbabwe.,Cancerserve Trust, Harare, Zimbabwe
| |
Collapse
|
3
|
Shang C, Feng L, Gu Y, Hong H, Hong L, Hou J. Impact of Multidisciplinary Team Management on the Survival Rate of Head and Neck Cancer Patients: A Cohort Study Meta-analysis. Front Oncol 2021; 11:630906. [PMID: 33763367 PMCID: PMC7982739 DOI: 10.3389/fonc.2021.630906] [Citation(s) in RCA: 15] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2020] [Accepted: 02/16/2021] [Indexed: 12/24/2022] Open
Abstract
Background: Head and neck cancer (HNC) is one of the more common malignant tumors that threaten human health worldwide. Multidisciplinary team management (MDTM) in HNC treatment has been introduced in the past several decades to improve patient survival rates. This study reviewed the impact of MDTM on survival rates in patients with HNC compared to conventional treatment methods. Methods: Only cohort studies were identified for this meta-analysis that included an exposure group that utilized MDTM and a control group. Heterogeneity and sensitivity also were assessed. Survival rate data for HNC patients were analyzed using RevMan 5.2 software. Results: Five cohort studies (n = 39,070) that examined survival rates among HNC patients were included. Hazard ratios (HR) were calculated using the random effect model. The results revealed that exposure groups treated using MDTM exhibited a higher survival rate [HR = 0.84, 95% CI (0.76–0.92), P = 0.0004] with moderate heterogeneity (I2 = 68%, p = 0.01). For two studies that examined the effect of MDTM on the survival rate for patients specifically with stage IV HNC, MDTM did not produce any statistically significant improvement in survival rates [HR = 0.81, 95% CI (0.59–1.10), p = 0.18]. Conclusions: The application of MDTM based on conventional surgery, radiotherapy, and chemotherapy improved the overall survival rate of patients with HNC. Future research should examine the efficacy of MDTM in patients with cancer at different stages.
Collapse
Affiliation(s)
- Changyi Shang
- Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China
| | - Linfei Feng
- Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China
| | - Ying Gu
- Department of General Dentistry, School of Dental Medicine, Stony Brook University, Stony Brook, NY, United States
| | - Houlin Hong
- Program in Public Health, Stony Brook Medicine, Stony Brook University, Stony Brook, NY, United States
| | - Lilin Hong
- Department of General Dentistry, The Fourth Affiliated Hospital of Anhui Medical University, Hefei, China
| | - Jun Hou
- Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China
| |
Collapse
|